178eP Stromal APOL4 defines an immune-activating fibroblast subtype that predicts platinum response across cancers
Year: 2026
Type: article
Abstract: Platinum-based chemotherapy is widely used in solid tumors, but most patients ultimately develop resistance. While tumor-intrinsic mechanisms have been extensively studied, the contribution of stromal components remains unclear.
Source: ESMO Open
Author: J-K. Lee
Institution: Seoul National University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7147616907
FWCI:
Cites:
Cited by:
Related to:
